pharma · Leukemia · Acute Myeloid Leukemia
Shanghai Medical College
Children's Hospital of Fudan University
Children's Hospital of is a pharma organization headquartered in CN. Primary therapeutic focus areas include Leukemia, Acute Myeloid Leukemia, Childhood Germ Cell Tumor, Juvenile Myelomonocytic Leukemia, Central Nervous
CN HQ
20 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Employees
- 20
- Programs
- 20
- Drugs
- 22
- Patents
- 0
Dinutuximab
Phase 2 · mab · High Risk Neuroblastoma
Dinutuximab for High Risk Neuroblastoma is a Phase 2 program (mab) at Children's Hospital of Fudan University with 1 ClinicalTrials.gov record(s).
Internal code ANBL1821
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Children's Hospital of Fudan University
- Phase
- Phase 2
- Modality
- mab
- Indication
- High Risk Neuroblastoma
- Status
- active
- Trials
- 1